Skip to main navigation Skip to search Skip to main content

Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta

  • Katarina Le Blanc
  • , Cecilia Götherström
  • , Olle Ringdén
  • , Moustapha Hassan
  • , Robert McMahon
  • , Edwin Horwitz
  • , Göran Anneren
  • , Ove Axelsson
  • , Janice Nunn
  • , Uwe Ewald
  • , Solveig Nordén-Lindeberg
  • , Monika Jansson
  • , Ann Dalton
  • , Eva Aström
  • , Magnus Westgren
  • Karolinska University Hospital
  • Sheffield Children's NHS Foundation Trust
  • St. Jude Children's Research Hospital
  • Uppsala University
  • Kosair Children's Hospital

Research output: Contribution to journalArticlepeer-review

430 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSC) are progenitors of mesenchymal tissues such as bone, cartilage, and adipose. Adult human leukocyte antigen (HLA)-matched MSC have been used in cellular therapies of bone disorders such as osteogenesis imperfecta, with promising results.
Original languageEnglish
Pages (from-to)1607-1614
Number of pages8
JournalTransplantation
Volume79
Issue number11
Publication statusPublished - 15 Jun 2005
Externally publishedYes

Keywords

  • Adult
  • Biopsy
  • Bone and Bones
  • Collagen
  • Collagen Type I
  • DNA Primers
  • Female
  • Fetal Tissue Transplantation
  • Gestational Age
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • Humans
  • In Situ Hybridization, Fluorescence
  • Infant
  • Infant, Newborn
  • Male
  • Mesoderm
  • Osteogenesis Imperfecta
  • Pregnancy
  • Pregnancy Complications
  • Stem Cell Transplantation
  • Transplantation Chimera

Fingerprint

Dive into the research topics of 'Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta'. Together they form a unique fingerprint.

Cite this